Sotorasib Phase 1 Non-Small Cell Lung Cancer Data From the CodeBreaK 100 Clinical Study
First Clinical Data Disclosure for Investigational AMG 160, a Half-Life Extended PSMA-Targeted BiTE® Molecule
PR Newswire
THOUSAND OAKS, Calif., Sept. 16, 2020